|
1) Flegal KM, Carroll MD, Ogden CL, et al. Plevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303: 235-41
|
|
|
|
2) Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997; 88: 131-41
|
|
|
|
|
|
3) Elias CF, Lee C, Kelly J, et al. Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron. 1998; 21: 1375-85
|
|
|
|
|
|
4) Kristensen P, Judge ME, Thim L, et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature. 1998; 393: 72-6
|
|
|
|
|
|
5) Abbott CR, Rossi M, Wren AM, et al. Evidence of an orexigenic role for cocaine- and amphe-tamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinol. 2001; 142: 3457-63
|
|
|
|
|
|
6) Asnicar MA, Smith DP, Yang DD, et al. Absence of cocaine-and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinol. 2001; 142: 4394-400
|
|
|
|
|
|
7) Kong WM, Stanley S, Gardiner J, et al. A role for arcuate cocaine and amphetamine-regulated transcript in hyperphagia, thermogenesis, and cold adaptation. FASEB J. 2003; 17: 1688-90
|
|
|
|
|
|
8) Clark JT, Kalra PS, Crowley WR, et al. Neuro-peptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinol. 1984; 115: 427-9
|
|
|
|
|
|
9) Bewick GA, Gardiner JV, Dhillo WS, et al. Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J. 2005; 19: 1680-2
|
|
|
|
|
|
10) Kohno D, Sone H, Tanaka S, et al. AMP-activated protein kinase activates neuropeptides Y neurons in the hypotalamic arcuate nucleus to increase food intake in rats. Neurosci Lett. 2011; 499: 194-8
|
|
|
|
|
|
11) Kohno D, Gao HZ, Muroya S, et al. Ghrelin directly interacts with neuropeptide-Y containing neurons in the rat arcuate nucleus. Diabetes. 2003; 52: 948-56
|
|
|
|
|
|
12) Andrews ZB, Li ZW, Wallingford N, et al. UCP2 mediates ghrelinʼs action on NPY/AgRP neurons by lowering free radicals. Nature. 2008; 454: 846-51
|
|
|
|
|
|
13) Date Y, Murakami N, Toshinai S, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterol. 2002; 123: 1120-8
|
|
|
|
|
|
14) Cowley MA, Smith RG, Diano S, et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 2003; 37: 649-61
|
|
|
|
|
|
15) Christensen MT, Vrang N, Larsen PJ. Glucagon-like peptide containing pathways in the regulation of feeding behavior. Inter J Obesity. 2001; 25: S42-7
|
|
|
|
|
|
16) Abbott CR, Monterio M, Small CJ, et al. The inhibitory effects of peripheral administration of peptide YY3-36 and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 2005; 1044: 127-31
|
|
|
|
|
|
17) Hayes MR, Leichner TM, Zhao S, et al. Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation. Cell Metab. 2011; 13: 320-30
|
|
|
|
|
|
18) Olson BR, Drutarosky MD, Stricker EM, et al. Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake. Endocrinol. 1991; 129: 785-91
|
|
|
|
|
|
19) Arletti R, Benelli A, Bertolini A. Influence of oxytocin on feeding behavior in the rat. Peptides. 1989; 10: 89-93
|
|
|
|
|
|
20) Swaab DF, Purba JS, Hofman MA. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metab. 1995; 80: 573-9
|
|
|
|
|
|
21) Maejima Y, Sedbazar U, Suyama S, et al. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab. 2009; 10: 355-65
|
|
|
|
|
|
22) Stengel A, Goebel M, Wang L, et al. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinol. 2009; 150: 4911-9
|
|
|
|
|
|
23) Iwasaki Y, Nakabayashi H, Kakei M, et al. Nesfatin-1 evokes Ca2＋ signaling in isolated vagal afferent neurons via Ca2＋ influx through N-type channels. Biochem Biophys Res Commun. 2009; 90: 958-62
|
|
|
|
|
|
24) Shimizu H, Oh-I S, Hashimoto K, et al. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinol. 2009; 150: 662-71
|
|
|
|
|
|
25) Fujitsuka N, Asakawa A, Uezono Y, et al. Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival. Transl Psychiatry. 2011; 1: e23-32
|
|
|
|
|